Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Cubero

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell ReprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Journal of Hepatology|April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Biomedicines|October 23, 2021
Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, et al.
Frontiers in Immunology|July 17, 2023
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stressBeatriz Martín-Adrados, Stefanie K Wculek, Sergio Fernández-Bravo, et al.
Cancers|January 11, 2022
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver DiseaseChaobo Chen, Hanghang Wu, Hui Ye, et al.
Cancers|January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized TherapyFeifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Gut|July 21, 2021
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary stricturesMaria Arechederra, María Rullán, Irene Amat, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from AcetaminophenRubén Rodríguez-Agudo, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, et al.
Nature|April 12, 2019
p38γ is essential for cell cycle progression and liver tumorigenesisAntonia Tomás-Loba, Elisa Manieri, Bárbara González-Terán, et al.
Hepatology Communications|June 18, 2021
An Experimental DUAL Model of Advanced Liver DamageRaquel Benedé-Ubieto, Olga Estévez-Vázquez, Feifei Guo, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|April 17, 2023
Hepatocyte Dedifferentiation Profiling In Alcohol-Related Liver Disease Identifies CXCR4 As A Driver Of Cell ReprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Journal of Hepatology|April 23, 2023
Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogrammingBeatriz Aguilar-Bravo, Silvia Ariño, Delia Blaya, et al.
Biomedicines|October 23, 2021
Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Feifei Guo, et al.
Frontiers in Immunology|July 17, 2023
Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stressBeatriz Martín-Adrados, Stefanie K Wculek, Sergio Fernández-Bravo, et al.
Cancers|January 11, 2022
Activation of the Unfolded Protein Response (UPR) Is Associated with Cholangiocellular Injury, Fibrosis and Carcinogenesis in an Experimental Model of Fibropolycystic Liver DiseaseChaobo Chen, Hanghang Wu, Hui Ye, et al.
Cancers|January 11, 2022
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized TherapyFeifei Guo, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, et al.
Gut|July 21, 2021
Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary stricturesMaria Arechederra, María Rullán, Irene Amat, et al.
Antioxidants (Basel, Switzerland)|May 28, 2022
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from AcetaminophenRubén Rodríguez-Agudo, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, et al.
Nature|April 12, 2019
p38γ is essential for cell cycle progression and liver tumorigenesisAntonia Tomás-Loba, Elisa Manieri, Bárbara González-Terán, et al.
Hepatology Communications|June 18, 2021
An Experimental DUAL Model of Advanced Liver DamageRaquel Benedé-Ubieto, Olga Estévez-Vázquez, Feifei Guo, et al.
Pageof 12